Observational Iranian journal of medical sciences · 2026 Integrative Metagenomic Analysis Reveals Human Gut Microbiome-Derived Candidate Non-invasive Biomarkers for Type II Diabetes Mellitus. Mujahid W, Safdar S, Aftab A, et al. [Ruminococcus] torquesBacteroides ovatusBacteroides stercorisBacteroides thetaiotaomicron +7 more PubMed ↗
Randomized trial Journal of diabetes investigation · 2026 Effects of age, sex, and renal function on bowel movement-improving effects of Bifidobacterium bifidum G9-1 on constipation in patients with type 2 diabetes mellitus and chronic kidney disease: A prespecified subgroup analysis of the BIRDIE study. Ikeda F, Sato J, Yoshii H, et al. Bifidobacterium bifidum PubMed ↗
Review Progress in neuro-psychopharmacology & biological psychiatry · 2026 Vitamin B12-mediated microglial immunometabolic reprogramming: A novel mechanistic insight into diabetes-associated cognitive impairment. Zhang X, Li J, An Y, et al. Akkermansia muciniphila PubMed ↗
Review Medicina · 2026 Gut Microbiota in Metabolic Syndrome: Differences in Microbial Signatures and Clinical Profiles. Scarlata GGM, Belančić A, Scarpellini E, et al. Akkermansia muciniphila PubMed ↗
Review Frontiers in endocrinology · 2026 Gut microbiota in type 2 diabetes mellitus: mechanistic links between dysbiosis, insulin resistance, and chronic low-grade inflammation. Chen Y, Jin D, Han X, et al. Faecalibacterium prausnitzii PubMed ↗
Observational Scientific reports · 2026 The gut microbiota and metabolomics in the pathogenesis of type 2 diabetes mellitus combined with coronary atherosclerotic heart disease. Huang L, Zhang X, Wu Y, et al. Anaerobutyricum halliiParaprevotella claraSutterella wadsworthensis PubMed ↗
Review Frontiers in endocrinology · 2026 Post-transplant diabetes mellitus after kidney transplantation: pathogenesis, risk factors, and management strategies. Long J, Zhao J, Gu X, et al. Akkermansia muciniphilaFaecalibacterium prausnitzii PubMed ↗
Randomized trial Diabetes, obesity & metabolism · 2026 Bifidobacterium bifidum G9-1 Intake Improves Gastrointestinal Symptoms in Type 2 Diabetes Mellitus: An Open-Label, Randomized Controlled Trial (Binary STAR Study). Kobayashi G, Hashimoto Y, Matsuyama T, et al. Bifidobacterium bifidum PubMed ↗
Randomized trial Food research international · 2026 Timing matters in type 2 diabetes: Early high-Fiber nutrition enhances glycemic control and reshapes gut microbiota. Wang L, Liang C, Yu J, et al. Akkermansia muciniphila PubMed ↗
Observational Nutrition & diabetes · 2026 Multi-cohort analysis of metagenome for type 2 diabetes identified universal gut microbiota signatures across populations. Dong Y, Wang M, Zhou X, et al. Enterocloster bolteaeEnterocloster citroniaeHaemophilus parainfluenzae PubMed ↗
Observational Obesity surgery · 2026 Gut Microbiota-specific Profile Prior to Surgery for Predicting Type 2 Diabetes Remission in Patients Undergoing Sleeve Gastrectomy. Martínez-Montoro JI, Sancho-Marín R, Garrido-Sánchez L, et al. Mediterraneibacter gnavus PubMed ↗
Observational Gut microbes · 2026 Parasutterella excrementihominis is associated with attenuated metabolic improvements during obesity therapy in humans. Liu S, Schlicht K, Beckmann A, et al. Parasutterella excrementihominis PubMed ↗
Clinical trial Journal of diabetes investigation · 2026 Efficacy of probiotics (Bifidobacterium bifidum G9-1) in patients with type 2 diabetes mellitus and chronic kidney disease complicated by constipation: An exploratory, multicenter, open-label, single-arm study (BIRDIE study). Ikeda F, Sato J, Yoshii H, et al. Bifidobacterium bifidum PubMed ↗
Review Nutrients · 2025 Intermittent Fasting and Probiotics for Gut Microbiota Modulation in Type 2 Diabetes Mellitus: A Narrative Review. Zhang Z, Wang S, Sun G, et al. Akkermansia muciniphilaFaecalibacterium prausnitzii PubMed ↗
Review Diabetes research and clinical practice · 2025 Differential gut microbiome profiles in diabetic retinopathy: A comparative study across continental populations. Adhikary P, Maddheshiya A, Takkar B, et al. Alistipes finegoldiiAnaerobutyricum hallii PubMed ↗
Observational Journal of gastroenterology · 2025 An endoscopic real-time, in situ assessment of intestinal permeability in type 2 diabetes: links to microbiota and hyperglycemia. Kimura Y, Minoda Y, Ihara E, et al. Phocaeicola vulgatus PubMed ↗
Review Journal of basic and clinical physiology and pharmacology · 2025 The role of the urinary microbiome in diabetes-associated UTIs: current understanding and future directions. Yathindra MR, Badugu R, Singh SK, et al. Escherichia coli PubMed ↗
Review Medicina · 2025 The Gut Microbiota-Metabolic Axis: Emerging Insights from Human and Experimental Studies on Type 2 Diabetes Mellitus-A Narrative Review. Alqahtani MS Faecalibacterium prausnitziiRoseburia intestinalis PubMed ↗
Meta-analysis Nutrition, metabolism, and cardiovascular diseases · 2025 Mediterranean diet, gut microbiota, and type 2 diabetes: A systematic review and meta-analysis of intervention trials. Lauria F, Formisano A, Dello Russo M, et al. Akkermansia muciniphila PubMed ↗
Randomized trial Diabetes research and clinical practice · 2025 Effects of home-based exercise training on gut microbiota and possible relations with cognitive function and metabolic health in postmenopausal women with type 2 diabetes mellitus: a randomized control trial. Vahed A, Molanouri Shamsi M, Siadat SD, et al. Akkermansia muciniphila PubMed ↗
Randomized trial Journal of diabetes and its complications · 2025 The effects of Bifidobacterium animalis subsp. lactis BLa80 on glycemic control and gut microbiota in patients with T2DM: a randomized, double-blind, placebo-controlled trial. Zhao C, Lu X, Deng X, et al. Bifidobacterium animalis PubMed ↗
Randomized trial Nutrients · 2025 Bifidobacterium animalis subsp. lactis TISTR 2591 Improves Glycemic Control and Immune Response in Adults with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Crossover Clinical Trial. Khiaolaongam W, Boonyapranai K, Sitdhipol J, et al. Bifidobacterium animalis PubMed ↗
Randomized trial Gut microbes · 2025 Systemic and gut microbiome changes with metformin and liraglutide in youth-onset type 2 diabetes: the MIGHTY study. Glaros SB, Mishra SP, Jain S, et al. Agathobacter rectalisBacteroides fragilisStreptococcus thermophilus PubMed ↗
Meta-analysis Frontiers in cellular and infection microbiology · 2025 Meta-analytical insight on probiotic metabolites and inflammatory markers in diabetes. Xie Y, Zheng Y, Jiang F, et al. Bifidobacterium longum PubMed ↗
Review Diabetes/metabolism research and reviews · 2025 Diabetes and Bone Health: A Comprehensive Review of Impacts and Mechanisms. Upadhyay P, Kumar S Akkermansia muciniphilaBacteroides fragilis PubMed ↗
Observational PeerJ · 2025 Fecal microbiome analysis in patients with metabolic syndrome and type 2 diabetes. Sinisterra Loaiza LI, Fernández-Edreira D, Liñares-Blanco J, et al. Dialister invisusDorea longicatenaRuminococcus callidus PubMed ↗
Randomized trial Gut microbes · 2025 Anaerobutyricum soehngenii improves glycemic control and other markers of cardio-metabolic health in adults at risk of type 2 diabetes. Attaye I, Bird JK, Nieuwdorp M, et al. Anaerobutyricum soehngeniiAnaerobutyricum hallii PubMed ↗
Observational Diabetes · 2025 Metabolic Dysfunction Associated With Alterations in Gut Microbiota in Adolescents With Obesity. Granato A, Xie QY, Wong A, et al. Escherichia coli PubMed ↗
Randomized trial Hormones · 2025 Comparative evaluation of dulaglutide alone vs. dulaglutide combined with probiotics on cardiovascular risk factors in T2DM. Tian J, Yang Y, Yu Z, et al. Bifidobacterium longum PubMed ↗
Observational Journal of translational medicine · 2025 Urobiome of patients with diabetic kidney disease in different stages is revealed by 2bRAD-M. Li N, Wang Y, Zhang H, et al. Enterococcus faecalis PubMed ↗
Observational Nature medicine · 2025 Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Wu H, Lv B, Zhi L, et al. Blautia wexlerae PubMed ↗
Randomized trial Cell metabolism · 2025 Akkermansia muciniphila supplementation in patients with overweight/obese type 2 diabetes: Efficacy depends on its baseline levels in the gut. Zhang Y, Liu R, Chen Y, et al. Akkermansia muciniphila PubMed ↗
Systematic review Frontiers in endocrinology · 2025 A systematic review on gut microbiota in type 2 diabetes mellitus. Chong S, Lin M, Chong D, et al. Faecalibacterium prausnitzii PubMed ↗
Observational Annals of epidemiology · 2024 Gut microbiome and obesity in late adolescence: A case-control study in "Children of 1997" birth cohort. He B, Xu S, Schooling CM, et al. Bacteroides uniformis PubMed ↗
Randomized trial Clinical nutrition · 2024 Effects of synbiotics surpass probiotics alone in improving type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial. Zhang C, Zhang Q, Zhang X, et al. Bifidobacterium animalis PubMed ↗
Review Postepy biochemii · 2024 [The role of gut microbiota and its metabolites in obesity and diabetes]. Raczkowska A, Arak K, Jaworska K Akkermansia muciniphila PubMed ↗
Observational Frontiers in endocrinology · 2024 Gut microbiota and metabolic profiles in adults with unclassified diabetes: a cross-sectional study. Zhang J, Wu L, Zhang Z, et al. [Ruminococcus] torques PubMed ↗
Meta-analysis Nutrients · 2024 Akkermansia muciniphila for the Prevention of Type 2 Diabetes and Obesity: A Meta-Analysis of Animal Studies. Liu E, Ji X, Zhou K Akkermansia muciniphila PubMed ↗
Review Virulence · 2024 Akkermansia muciniphila: A promising probiotic against inflammation and metabolic disorders. Zhao Y, Yang H, Wu P, et al. Akkermansia muciniphila PubMed ↗
Observational Metabolic syndrome and related disorders · 2024 Quantification and Correlation Analysis of Bacteroides Species with Diabetes-Related Amino Acids in Individuals with Prediabetes and Type 2 Diabetes Mellitus. Safari-Alighiarloo N, Bostanghadiri N, Sedighi M, et al. Bacteroides thetaiotaomicronPhocaeicola vulgatus PubMed ↗